Author:Wiendl, Heinz De Stefano, Nicola Barkhof, Frederik Montalban, Xavier Achiron, Anat Derfuss, Tobias Chan, Andrew Hodgkinson, Suzanne Prat, Alexandre Leocani, Letizia Schmierer, Klaus Sellebjerg, Finn Vermersch, Patrick Jin, Hulin Jarvinen, Elina Chudecka, Anita Gardner, Lidia
Session Name:S16: MS Clinical Trials and Therapeutics
Topic:MS and Inflammatory Disease
Program Number:S16.006
Author Institution:University of Muenster, Muenster, Germany Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy VU University Medical Center, Amsterdam, Netherlands Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d’Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain Multiple Sclerosis Center, Sheba Academic Medical Center, Ramat Gan, Israel University Hospital Basel, Basel, Switzerland Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland Ingham Institute for Applied Medical Research, University of New South Wales Medicine, Sydney, Australia Université de Montréal, Montreal, QC, Canada Experimental Neurophysiology Unit, Vita-Salute San Raffaele University, Milan, Italy The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, United Kingdom Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France the healthcare business of Merck KGaA, Darmstadt, Germany, Darmstadt, Germany Cytel Inc. Geneva, Switzerland, Geneva, Switzerland EMD Serono, Billerica, MA, USA, Billerica, MA
Author:Montalban, Xavier Wolinsky, Jerry S. Arnold, Douglas L. Weber, Martin S. Piasecka-Stryczynska, Karolina Tomic, Davorka Seitzinger, Andrea Guehring, Hans
Session Name:S16: MS Clinical Trials and Therapeutics
Topic:MS and Inflammatory Disease
Program Number:S16.008
Author Institution:Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d'Hebron, Barcelona, Spain McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX NeuroRx Research, and Montreal Neurological Institute, Montreal, QC, Canada Institute of Neuropathology and the Department of Neurology, University Medical Center, University of Göttingen, Göttingen, Germany Poznan University of Medical Sciences, Poznan, Poland Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany , Eysins, Switzerland the healthcare business of Merck KGaA, Darmstadt, Germany, Darmstadt, Germany
Author:Servais, Laurent Oskoui, Maryam Day, John Deconinck, Nicholas Mazzone, Elena Nascimento, Andrés Saito, Kyoko Vuillerot, Carole Baranello, Giovanni Boespflug-Tanguy, Odile Goemans, Nathalie Kirschner, Janbernd Kostera-Pruszczyk, Anna Braid, Jessica Papp, Gergely Gorni, Ksenija Martin, Carmen Scalco, Renata Yeung, Wai Yin Mercuri, Eugenio
Session Name:S34: Child Neurology and Developmental Neurology 2
Topic:Child Neurology and Developmental Neurology
Program Number:S34.009
Author Institution:IMotion Institut de Myologie AP-HP, Hôpital Armand Trousseau, Paris, France MDUK Oxford Neuromuscular Centre, Department of Paediatrics, University of Oxford, Oxford, UK Division of Child Neurology, Centre de Références des Maladies Neuromusculaires, Department of Pediatrics, University Hospital Liège & University of Liège, Liège, Belgium, Oxford, United Kingdom
Author:Bermel, Robert Hartung, Hans-Peter Brochet, Bruno Benedict, Ralph Berger, Thomas Carroll, William Vollmer, Timothy Holmoy, Trygve Karabudak, Rana Killestein, Joep Nos, Carlos Patti, Francesco Perrin Ross, Amy Vanopdenbosch, Ludo Wuerfel, Jens Kuenzel, Thomas Kadner, Karen Kulyk, Inessa Freedman, Mark
Session Name:S46: MS Therapeutics and Clinical Decision Making
Topic:MS and Inflammatory Disease
Program Number:S46.004
Author Institution:Mellen Center for MS, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH Deptartment of Neurology, Heinrich-Heine-University Düsseldorf, Germany, Dusseldorf, Germany Université de Bordeaux, Neurocentre Magendie INSERM, Bordeaux, France, Bordeaux, France Jacobs School of Medicine and Biomedical Sciences, Department of Neurology, University of Buffalo, NY, USA, Buffalo, NY Dept. of Neurology, Medical University of Vienna, Vienna, Austria Department of Neurology, Sir Charles Gairdner Hospital, Perron Institute for Neurological and Translational Science, The University of Western Australia, Nedlands, Australia, Subiaco, Australia Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA, Aurora, CO Department of Neurology, Akershus University Hospital, Lørenskog, Norway, Lasker, Norway Department of Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey, Ankara, Turkey Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands, Amsterdam, Netherlands Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Vall d’Hebron Hospital Universitari, Barcelona, Spain, Barcelona, Spain Department of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia, Neuroscience Section and Multiple Sclerosis Centre, University of Catania PO Policlinico G Rodolico, Catania, Italy, Catania, Italy Loyola University Chicago, Chicago, IL, USA, Oak Brook, IL Department of Neurology, AZ Sint-Jan Brugge-Oostende, Brugge, Belgium, Brugge, Belgium F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland University of Ottawa, Department of Medicine and the Ottawa Hospital Research Institute Ottawa, ON, Canada., Ottawa, ON, Canada
Author:Levy, Michael Sortichos, Elias Zephir, Hélène Pique, Julie Carment, Loïc Gorin, Clarissa Kapche Kamga, Sonia Ravindra, Dellini Touré Cuq, Emma Fam, Sami Kielhorn, Adrian Aras, Emrah de Sèze, Jérôme
Session Name:S50: Autoimmune Neurology: NMOSD
Topic:Autoimmune Neurology
Program Number:S50.002
Author Institution:Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, USA, Boston, MA Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, USA, Baltimore, MD Department of neurology, University of Lille, U Inserm 1172, CHU of Lille, France, Lille, France Centre de référence des maladies inflammatoires rares du cerveau et de la moelle (MIRCEM), Service de neurologie, sclérose en plaques, Pathologies de la myéline et neuro-inflammation, Hôpital Neurologique Pierre Wertheimer Hospices Civils de Lyon, Lyon, France, Lyon, France Ad Scientiam, Paris, France, Paris, France Alexion Pharmaceuticals Inc., Boston, MA 02210, USA, Boston, MA Department of Neurology, Hôpital Civil, Strasbourg University, Strasbourg, France, Strasbourg, France